Join us as we bring together healthcare, technology, government and communication leaders to discuss opportunities and challenges in the growing field of mobile and information technologies for health. Engage with entrepreneurs and the venture community who are fundamentally transforming healthcare by creating and financing cutting-edge technological innovations. This transformation offers unprecedented opportunities for providing new and improved models of healthcare delivery in support of improving quality of patient care, increasing efficiencies and accountability, and decreasing cost of care. There are legislative challenges to be faced and the role of government, “smart” regulation and standards in the future of health will be discussed. Come listen to and meet experts in the field.
Speaker: Dr. Sophia Chang, California Healthcare Foundation | Dr. Jeffrey Kaye, Oregon Health & Science University | Lisa Hammann, Genentech | Don Ross, HealthTech Capital | David Sayen, Collaborations for Health | Wil Yu, U.S. Dept. of Health & Human Services
Date and Time: Wednesday, May 16, 2012 | 8:00 AM – 3:30 PM
Location: Sobrato Center for Non-Profits, 330 Twin Dolphin Drive, Redwood City
Cost:
General Public: $150
SVForum members: $130
Platinum Pass: $80
Students: $75
On-site registration: Additional $40 (does not apply to Platinum Pass Members)
30% OFF Discount Code for BioCenter Members: DATA12

This intensive course including two days of classroom and balance of term for individual research is designed to provide participants with an understanding of the critical role business development and licensing functions play in the commercialization of new products or technology and to the development of a successful life science company. The term assignment is designed to give students the opportunity to put the knowledge and materials from class to immediate and practical use with resulting document for inclusion in their portfolio.
Upon successful completion of the course, participants will:
• Understand the various aspects of the business development function in the life science industry and appreciate the skills required to be effective in business development and licensing roles
• Appreciate types of deals and their role in commercialization strategies and funding of a company
• Understand importance of IP status and patent life cycle planning
Course Instructor: Audrey Erbes, Ph.D., is a global life-science business development and marketing consul-tant, industry educator, organization leader and public speaker who originated several bioscience business development and marketing courses at the UCB and UCSC Extensions. She is known for her industry blog publications on Audreysnetwork.com.
Date and Time: Thursday and Friday, June 21-22, 2012; 8:30 am – 5:00 pm for classroom intensive and balance of term for working on term project
Location: Downtown University of California, Berkeley Extension, 425 Market St., 8th Floor, San Francisco, CA 94105
Cost: $895

Technology Vision Group, LLC invites Biotech companies to apply for an opportunity to present at C21 BioVentures. Selected companies will compete for the first annual Biotech Rising Star Award. Early stage innovators have an opportunity to showcase their technology and to network with potential partners for funding sources.
Presenters will be selected on the following criteria: business market potential, technology and profile quality. The selection process will be completed by the 2012 C21 Advisory Board selection committee and TVG. The Biotech Rising Star Award will be awarded to the top presenting company at an exclusive invitation only venture capital investor/presenter mixer. The mixer will be held at the Meritage Resort on May 23 from 5:15 – 6:15p.m.
This is an opportunity to connect with pharam scouts, venture capitalists, investors and VP’s of business development. Last year’s participates included partners from Abbott, Amgen, Abingworth, Novo, Silicon Valley Bank, and TVM Capital as well as decision makers from Merck and AstraZeneca to name a few. The 2011 participant summary breakdown shows over 344 delegates and 249 companies from 15 countries came to C21. There were 797 meetings scheduled through biopartnering.com.
The conference will be held at the Meritage Resort on May 22-24, 2012. This intimate venue is designed for small –privately held enterprises to showcase innovation and to network with potential partners for funding sources. Schedule face to face meetings using biopartnering.com software.
At C21 you will discover unconventional sources of capital from around the globe. Find out answers to questions concerning securing corporate venture capital funding and business models that are attractive to pharma venture arms. Join in lively discussions and arrange face to face meetings with pharma scouts that are seeking licensing deals for their next R&D facility. Learn about Biosimilars and how they may lead to branded versions of biological products.
Date and Time: May 22-24, 2012
Location: The Meritage Resort, Napa, CA
Cost:
General Rate (ends May 18): $1,900
Onsite Rate (starts May 19):$2,000
Get a 10% Discount with Promotion Code "SJBio2012" ($1,710 to $1,900)

Personalized Medicine 5.0: The Role of Epigenetics, focuses on the exciting area of epigenetics, or genetic change above and beyond the DNA sequence level, with profound implications for personalized medicine, pharmacogenomics, aging and oncology. Personalized medicine is poised to transform healthcare over the next several decades, offering the possibility of improved health outcomes and making healthcare more cost-effective. Yet it has become abundantly clear that the DNA sequence itself is only part of the story. Join us for Personalized Medicine 5.0 and witness the transformation as it is happening!

Date and Time: Thursday, May 24, 2012, 8:00 am -7:30 pm
Location:South San Francisco Conference Center, South San Francisco, CA
Cost:
Early Registration: $395.00
Registration: $495.00

Ryan and Karen will cover COR Innovations' solution to preventing congestive heart failure (CHF), following myocardial infarction (i.e. heart attack) with a minimally-invasive, device-based technology. Our presentation will include some background and statistics on CHF, previously proposed treatments as well as their shortcomings and finally our device. We will also cover our current testing and proposed future animal studies and experiments.
Speaker: Ryan Krone, Senior Mechanical Engineer & Karen Havenstrite, Chief Scientific Officer, both at COR Innovations
Date and Time: Tuesday, May 29, 2012, 8:30 am
Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA
(across the street from Sunnyvale Public Library)
Cost: Free

Have you ever iterated? You're in good company. No product design is born perfect and complete. However, as development goes on, design changes and bug fixes become more and more costly—and time-consuming. One of the most cost-effective ways to reduce these costs is to execute comprehensive system modeling early on. While many specialized solutions exist to model certain subdomains (e.g., optical propagation software, CAD packages, etc.), they typically don't tell the designer how the system as a whole will behave in response to design choices. Our design approach at Kinetic River can drastically reduce trial-and-error by providing interactive and intuitive system modeling tools. We build the critical parameters of a system into a live, hands-on simulation tool that can be used to explore a wide range of design choices—and to trigger system decisions with confidence. I will showcase our approach for reducing development risks—while making the design process a lot more fun.
Speaker: Giacomo Vacca, Ph. D., Founder and President, Kinetic River Corporation
Date and Time: Tuesday, June 5, 2012, 8:30 am
Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA
(across the street from Sunnyvale Public Library)
Cost: Free

The Biospecimens and Biorepositories Conference is designed to bring leading industry, academic, and government experts to discuss developing trends and innovations in biobanking. Delegates will receive guidance and updates on regulatory and ethical considerations, including an investigation into international regulations and the ethics of using pediatric biospecimens. We’ll also explore novel strategies and techniques in biospecimen science, such as bioinformatics, and sample standardization and quality control, to increase biospecimen viability. Moreover, attendees will hear directly from scientists and researchers about emerging uses in personalized medicine and disease study.
Speaker: click here
Date and Time: June 7-8, 2012
Location: San Diego, CA
Cost: Commercial: $1795 (35% BioCenter discount: $1166.75)
Academic/gov: $845 (35% BioCenter discount: $549.25)
Student: $695 (35% BioCenter discount: $451.75)
To register with the 35% discount, please enter the discount code "BIO35RS" on the registration page before May 20, 2012.

The US Food and Drug Administration (FDA) released new draft guidance for industry on February 17, 2012 on how sponsors and applicants should submit standardized study data to FDA in electronic format. With the latest draft guidance released in February it is clear that the agency is being more aggressive in its 'recommendations' about the use of data standards. Join us on June 19 and learn how to navigate and benefit from the new draft FDA Guidance on Standardized Study Data:

Presentation Objectives:

• Gain an understanding of new draft FDA Guidance on Standardized Study Data released February 2012. This guidance establishes FDA's recommendation that sponsors and applicants submit study data in a standardized electronic format
• Comprehension of importance of standards for data collection through to submission of data for a product filing and approval. Understanding of the standards recommended from a timing and trial phase perspective; applies to biologics, medical devices and pharmaceuticals
• Provide an awareness of the updates to the current standards in use
• Discussion of how the latest eClinical technologies can effectively and efficiently help companies comply with FDA guidance while also expediting clinical decisions and submissions

Speaker: Thamar Draper, Senior Director, Professional Services and Product Management, OmniComm Systems Inc.
Date and Time: Tuesday, June 19, 2012, 8:30 am
Location: Sunnyvale City Council Chambers, 456 W. Olive, Sunnyvale, CA
(across the street from Sunnyvale Public Library)
Cost:
Free

The New York Venture Summit, presented by youngStartup Ventures is the premier industry gathering where cutting-edge startups meet top venture capitalists, angel investors, Corporate VCs and investment bankers. Whether you are an investor seeking new deals, or an emerging company seeking capital and exposure, the The New York Venture Summit, is one event you won’t want to miss.
Speakers: More than 40 leading VCs will speak at the Summit.
Date and Time: June 27-28, 2012
Location: Digital Sandbox in New York City
Cost:
Discounted rate for BioCenter members! Mor info coming soon...

Externalization through partnering and collaboration is essential to the future success of the pharmaceutical and biotechnology industry. BioPartnering Future Europe™ (BPFE) 2012 is a highly focused deal making conference in Europe, with Europe for the World. With support from the European Commission and a consortium of collaborators, BPFE has been designed to create an arena for partnering and collaborating that will ensure the future success of this industry. At the same time, BPFE will address all levels of business including capital raising, finance, policy issues, innovation in drug development, small and medium enterprises (SME’s) and the regulatory process.
Date and Time: October 7-9, 2012
Location: The Square, Brussels, Belgium
Cost:
Early Bird Rate (ends August 27): $1,950
General Rate (Aug 28 - Oct 5): $2,350
Onsite Rate (starts Oct 5) $2,600
Get a 10% Discount with Promotion Code "SJBio2012" ($1,710 to $1,900)

The BioExec Institute is an internationally renowned executive program delivered by leaders in the industry to director and vice president level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry.
Alongside BioExec Institute faculty and alumni, attendees will participate in a six-day (3 modules of 2 days each) interactive program, including three evening networking receptions. Participants will have unique opportunities to discuss and debate the strategies and tactics of business leadership within BioPharma and will complete the program with invaluable insight and powerful networks to deliver bottom-line value in this growing industry.
Day 0: Opening Night Welcome Reception
Day 1 - New Models of Innovation: Where does innovation come from and how do we get more of it? There are few more important questions to the biopharma industry and this year's BioExec Institute will feature some of the industries most respected thought leaders on the subject of innovation including Bernard Munos, Founder, InnoThink Center for Research in Biomedical Innovation and Mervyn J. Turner, Ph.D., Chief Strategy Officer, Merck & Co. Inc. & Sr. Vice President, Emerging Markets, Merck Research Laboratories.
Day 2 - Disruptive Innovation: A focus on innovative and/or niche models represented at specific companies which may or may not evolve into mainstream strategies. A high-level view of where current strategic investments are being made by ‘traditional’ biopharmas.
Date: October 9-10, 2012
Location: Center for Executive Development at the Haas School of Business, UC Berkeley, 2220 Piedmont Avenue, S-480, Berkeley, CA 94720
Cost:
1 Module: $2,400
Full Program - Regular Registration: $6,900
Full Program - Early Enrollment Registration (by June 25, 2012): $5,500
Full Program - Program Scholarships: $3,000
Full Program - Corporate Special (3 registrations): $18,600

The BioExec Institute is an internationally renowned executive program delivered by leaders in the industry to director and vice president level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry.
Alongside BioExec Institute faculty and alumni, attendees will participate in a six-day (3 modules of 2 days each) interactive program, including three evening networking receptions. Participants will have unique opportunities to discuss and debate the strategies and tactics of business leadership within BioPharma and will complete the program with invaluable insight and powerful networks to deliver bottom-line value in this growing industry.
Day 3: Strategic Product Positioning: Companies often start development on new or improved products because of great technological innovations in the lab. But, ultimately, it is the market - the customer - who decides whether your product is valuable or not. Planning for commercial success starts at the research stage and parallels the entire R&D process. During this session, industry leaders will explore product commercialization, second generation products and potential exit strategies, all in an effort to determine the best way to optimize the value of innovation over time. The content in this session will range from high-level strategic trade-offs to detailed calculations of value (both quantitative and qualitative) and from debating options to understanding the path for optimizing your company's assets.
Mid-Point Networking Reception
Day 4: Successfully Operating in a Global Regulatory Environment: Bringing products to market requires overcoming significant regulatory challenges for the goal of delivering on the safety and efficacy of the product. This session deals with the many gray areas of moving the product through the regulatory process, and understanding the various stakeholders' goals and political trade-offs in making the decision of whether or not to approve the product. Understanding the key questions that are core to each of the stakeholders unveils the secrets to getting a drug approved and plays an important role to a company's commercialization strategy. Topics covered in this session include, but not limited to, the importance of designing appropriate clinical trials to support a strong product label, DOJ and FDA specific promotional interests, substantial evidence, fair balance, understanding the basics of clinical support, medical affairs organizations and regulatory considerations, pre-approval activities, public relations programs, medical conventions, the EMEA and Japan regulatory requirements and how to meet those.
Date: November 7-8, 2012
Location: Center for Executive Development at the Haas School of Business, UC Berkeley, 2220 Piedmont Avenue, S-480, Berkeley, CA 94720
Cost:
1 Module: $2,400
Full Program - Regular Registration: $6,900
Full Program - Early Enrollment Registration (by June 25, 2012): $5,500
Full Program - Program Scholarships: $3,000
Full Program - Corporate Special (3 registrations): $18,600

The BioExec Institute is an internationally renowned executive program delivered by leaders in the industry to director and vice president level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry.
Alongside BioExec Institute faculty and alumni, attendees will participate in a six-day (3 modules of 2 days each) interactive program, including three evening networking receptions. Participants will have unique opportunities to discuss and debate the strategies and tactics of business leadership within BioPharma and will complete the program with invaluable insight and powerful networks to deliver bottom-line value in this growing industry.
Day 5 - Deal-Maker for a Day: Licensing and partnering are an integral part of the Biopharmaceutical industry. The formerly distinct pharmaceutical and biotechnology industries are merging into one interdependent Biopharmaceutical Industry. Partnered products are the future of innovation leading to a significant increase in attempts to acquire and/or license innovation from others. Big pharmaceutical companies will control fewer and fewer of their new products from discovery through line extension or OTC. This Day explores the underlying economics of deals; the different strategies for measuring risk; and how decisions are made amidst uncertainty.
Closing Networking Reception
Day 6 - CEO for a Day: Being a successful CEO is a mix of timing, teams and some say luck. On Day 6 of the BioExec Institute you will not only have the opportunity to dialogue with some of the industries most respected CEOs who will provide detailed and candid accounts of what really happened, but you will become a CEO for the day. You will be asked to make strategic decisions based on little to no information; you will be faced with contentious Board Members and disgruntled employees. What will your financing or exit strategy be and who will you be crowned the Winner of CEO for a Day by BioExec Faculty?
Date: December 6-7, 2012
Location: Center for Executive Development at the Haas School of Business, UC Berkeley, 2220 Piedmont Avenue, S-480, Berkeley, CA 94720
Cost:
1 Module: $2,400
Full Program - Regular Registration: $6,900
Full Program - Early Enrollment Registration (by June 25, 2012): $5,500
Full Program - Program Scholarships: $3,000
Full Program - Corporate Special (3 registrations): $18,600